ArriVent BioPharma (AVBP) Selling, General & Administrative (2023 - 2026)
ArriVent BioPharma's Selling, General & Administrative came in at $10.35 million for Q2 2026, up 75.4% from $5.9 million a year earlier and up 21.9% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Selling, General & Administrative (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, ArriVent BioPharma reported Selling, General & Administrative of $31.64 million, up 65.9% year-over-year; for FY2025, it was $24.18 million, up 58.0% from FY2024.
- Going back by year, Selling, General & Administrative was $15.3 million in FY2024 (+57.7%) and $9.71 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q1 2023.
- Year-over-year, Selling, General & Administrative has increased for ten consecutive quarters, with growth averaging 56.2% over the last eight quarters.
- The year-over-year growth in Selling, General & Administrative has ranged between 14.0% (Q4 2024) and 91.1% (Q1 2024) over the last five years.
- Business Quant data shows AVBP's Selling, General & Administrative at $8.49 million (Q1 2026), $6.65 million (Q4 2025) and $6.15 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | ArriVent BioPharma | 1.37 Bn | 1.37 Bn | - | 10.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.35 Mn |
| Mar 31, 2026 | 8.49 Mn |
| Dec 31, 2025 | 6.65 Mn |
| Sep 30, 2025 | 6.15 Mn |
| Jun 30, 2025 | 5.90 Mn |
| Mar 31, 2025 | 5.48 Mn |
| Dec 31, 2024 | 3.54 Mn |
| Sep 30, 2024 | 4.14 Mn |
| Jun 30, 2024 | 3.92 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 3.11 Mn |
| Sep 30, 2023 | 2.44 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | 1.94 Mn |
API Access
ArriVent BioPharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();